Abstract
This review article deals with different aspects of imidazole derivatives with one nitrogen atom bearing a substituted or unsubstituted phenyl moiety, such as their presence in bioactive compounds, their activity, as well as the main strategies for their preparation.
Keywords: imidazole synthesis, biological activity, pharmacological activity, imidazole derivatives
Current Chemical Biology
Title: Bioactive N-Phenylimidazole Derivatives
Volume: 3 Issue: 1
Author(s): Isidro M. Pastor and Miguel Yus
Affiliation:
Keywords: imidazole synthesis, biological activity, pharmacological activity, imidazole derivatives
Abstract: This review article deals with different aspects of imidazole derivatives with one nitrogen atom bearing a substituted or unsubstituted phenyl moiety, such as their presence in bioactive compounds, their activity, as well as the main strategies for their preparation.
Export Options
About this article
Cite this article as:
Pastor M. Isidro and Yus Miguel, Bioactive N-Phenylimidazole Derivatives, Current Chemical Biology 2009; 3 (1) . https://dx.doi.org/10.2174/2212796810903010065
DOI https://dx.doi.org/10.2174/2212796810903010065 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases
Current Cancer Drug Targets Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis
Anti-Cancer Agents in Medicinal Chemistry Stem Cell Behavior at Hypothermia: A Review Article
Current Stem Cell Research & Therapy CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
Anti-Cancer Agents in Medicinal Chemistry Naturally-occurring Dimers of Flavonoids as Anticarcinogens
Anti-Cancer Agents in Medicinal Chemistry Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?
Current Drug Metabolism Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Metabolic Fate of Endocannabinoids
Current Neuropharmacology α-Synuclein and the Pathogenesis of Parkinsons Disease
Protein & Peptide Letters Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
Current Neuropharmacology Antibody-Dependent Cell-Mediated Cytotoxicity Through Natural Killer (NK) Cells: Unlocking NK Cells for Future Immunotherapy
Current Pharmaceutical Biotechnology Sam Domains in Multiple Diseases
Current Medicinal Chemistry The Potential Role of Erythropoietin as a Pleiotropic Agent in Post-cardiac Arrest Syndrome
Current Pharmaceutical Design Biological Modulation by Lectins and Their Ligands in Tumor Progression and Metastasis
Anti-Cancer Agents in Medicinal Chemistry Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight
Recent Patents on Biotechnology Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy
Current Cancer Drug Targets Polyphenols: Well Beyond The Antioxidant Capacity: Gallic Acid and Related Compounds as Neuroprotective Agents: You are What You Eat!
Current Pharmaceutical Biotechnology A Combination of Two Antioxidants (An SOD Mimic and Ascorbate) Produces a Pro-Oxidative Effect Forcing Escherichia coli to Adapt Via Induction of oxyR Regulon
Anti-Cancer Agents in Medicinal Chemistry Cisplatin Resistance and Transcription Factors
Current Medicinal Chemistry - Anti-Cancer Agents Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
Current Pharmaceutical Design